Unstable angina articles from across Nature Portfolio

Findings from the ATPCI trial show that trimetazidine is safe but not protective against angina and cardiac events in the long term after percutaneous coronary intervention.

Ischaemic heart disease (IHD) causes a large number of deaths in the European Union, but a new study reveals important inequalities in IHD mortality between countries. Surveillance systems might help to identify these differences and define tailored treatment strategies, so that the burden of IHD can be reduced across Europe.

Over the past decade, the use of β-blockers has transformed the management and prognosis of patients with heart failure (HF). A post hoc analysis of the SENIORS study now raises questions about the validity of a composite 'ischemic' end point that includes sudden death in trials of β-blocker therapy for patients with HF.